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The neurologic deterioration after TBI is the direct effect of the primary injury (at the moment of impact) and secondary injuries during prehospital period and in the emergency department (delayed insults to the brain). It is obvious that the moment of impact is an independent factor from emergency medical service efforts. But what is done during the prehospital and initial hospital period is crucial to the patient's outcome.
Maintaining an adequate cerebral perfusion pressure (CPP) is the mainstay of therapy for the TBI patient. [2] [3] [4] We can evaluate CPP by monitoring the intracranial pressure (ICP) and the systemic blood pressure (continuously and invasively). Indications for ICP monitoring are known and transparent (Glasgow Coma Score 3 to 8 with abnormal computed tomography [CT] scan or two or more of the following adverse features: age Ͼ40 years, motor posturing, systolic blood pressure [SBP] Ͻ90 mm Hg). 1 The intracranial pressure sensor is implanted in the emergency department (ED) or the intensive care unit (ICU) after initial admission CT scan.
Noninvasive methods of ICP measurement useful in the ICU such as transcranial Doppler (TCD), visual-evoked responses (VERs), brain stem auditory-evoked responses (BAERs), ophthalmodynamometry, scalp blood flow (SBF) measured by Laser Doppler, and impedance audiometry are known but still experimental. [5] [6] [7] As far as our own experience is concerned, we wondered whether there was a correlation between ICP and the intraocular pressure (IOP), which would help to evaluate the CPP in the management of the critically ill patient.
Recent publications suggest a strong correlation between IOP and ICP. 8 But the physiologic mechanism responsible for elevations of IOP remains unclear. Salman 9 suggests that the cerebrospinal fluid (CSF) surrounding the optic nerve sheath transmits elevations of ICP through the eyeball, raising the IOP level. Other potential mechanisms suggest that the rise in the ophthalmic venous pressure (as the result of ICP elevation) could be transmitted directly to the ocular fluid raising IOP 10 or increased venous pressure in the cavernous sinus (also the direct effect of ICP rise) is transmitted to episcleral veins by the superior ophthalmic vein and becomes the cause of IOP increase. 11, 12 The results of another study 13 showed a linear correlation between the central retinal vein pressure and ICP. The venous outflow pressure of the central retinal vein was measured. This pressure (according to the study) reflects ICP because the central retinal vein passes through the optic nerve and then drains into the cavernous sinus and is independent from IOP. The method of measuring the central retinal vein pressure is called the ophthalmodynamometry. 14 There are also publications claiming no correlation between IOP and ICP. Hayreh 15 indicates that only an acute ICP increase of more than 50 mm Hg may cause significant increase of IOP. However, such enormous ICP increases are clinically rare phenomena and there is no anatomic and physiologic evidence for the statement that raised ICP is directly transmitted through the eyeball raising the IOP. The subarachnoid space around the optic nerve is separated from the eyeball by a fibrous tissue, which prevents the ICP transmission to the eye. According to researchers, a rapid rise in ICP to 50 mm Hg caused the increase in the ophthalmic venous pressure but had no significant effect on IOP. As far as the respiratory acidosis and alkalosis and prostaglandins (E1, E2, A) infusion that decreases both ICP and IOP is concerned, researchers claim that these changes represent independent physiologic roots and could not be regarded as evidence for a correlation between ICP and IOP.
PATIENTS AND METHODS
We investigated the correlation not only between IOP and ICP, but also between IOP and the mean arterial pressure (MAP), and ICP and MAP. We tried to evaluate if a rapid, noninvasive assessment of ICP was possible in a patient with suspected intracranial abnormality (during prehospital period, in ED or ICU) during a period when the intraparenchymal ICP sensor had not yet been implanted.
The study included invasive continuous monitoring of ICP using the intraparenchymal sensor, invasive continuous monitoring of arterial blood pressure, and measuring IOP using the Schioetz Tonometer. IOP measurement was conducted in 8-hour intervals and also when ICP had changed by 5 mm Hg or more. All IOP measurements were performed by the same person (Tomasz Czarnik) with the use of the same equipment. We investigated patients for whom ICP measurement was necessary on clinical grounds. We had the approval from the local ethics committee. Patients with a significant facial and ocular trauma, a history of glaucoma, and corneal disease were excluded.
The method of ICP monitoring included intraparenchymal placement of the intracranial pressure sensor (The MicroSensor-Codman, Johnson & Johnson Professional, Randolph, MA). The procedure usually took place in the operating room on the day of admission. The transducer was calibrated before insertion and then the sensor was advanced 3 to 4 cm into the brain parenchyma. The ICP pressure value of 20 mm Hg or less was regarded as normal. After 5 to 7 days of measurement, the intracranial pressure sensor was removed. 16 -23 Continuous invasive measurement of blood pressure was performed during ICP monitoring using standard bedside transducers leveled to the heart. 24 The IOP was measured by using the Schioetz Eye Tonometer (Rudolf Riester GmbH) in both eyes and a mean IOP was calculated. Immediately before the IOP measurement was taken, the tonometer was cleaned and then placed on the test block (testing procedure). If the pointer had been set to zero, the start of measurement was possible. The patient was in a recumbent position. The patient was sedated if it had been necessary for proper measurement and patient safety (to stop intracranial and hemodynamic response). The midazolam was used for sedation in a dose of 2 to 5 mg (0.05 mg/kg body weight) intravenously. After anesthetizing the cornea with a local anesthetic (Alcaine-Proxymetacaini hydrochloridum, Alcon-Couvreur), the tonometer was placed in a vertical position at the center of the cornea. Reliable pressure values were recorded when the pointer had shown a pulse. According to the manufacturer, the pressure of a healthy eye was approximately 16 mm Hg (average value).
The MAP, ICP, and IOP values were recorded in the measurement protocol at the same time. The approach to the therapy of patients followed general critical care principles and was CPP directed. All patients were initially mechanically ventilated (normoventilated) without positive end-expiratory pressure (PEEP) institution. 25 The management of elevated ICP included 15-degree head-up position, osmotherapy, mechanical normoventilation, avoidance of jugular venous obstruction, normovolemia, prevention of hyperthermia and hyperglycemia, moderate cooling, surgical intervention, and barbiturate coma as the last resort. The treatment for ICP was usually initiated at an upper threshold of 20 mm Hg. According to CPP, the aim was to maintain it above 60 mm Hg (above lower limit of autoregulation).
Twenty-two patients were joined in the study, 18 men and 4 women. There were no children in this group. In all, 287 measurements were performed (6 -19 per patient). Sixteen patients had elevated ICP (above 20 mm Hg): the lowest ICP was 5 mm Hg and the highest was 110 mm Hg. Thirteen patients had elevated IOP (above 16 mm Hg): the lowest IOP was 4.2 mm Hg and the highest was 46.9 mm Hg. There were TBI patients, subarachnoid hemorrhage (SAH) patients, and intracerebral hemorrhage (ICH) patients not associated with TBI (Table 1 ). In the TBI group, such intracranial pathological abnormalities as cerebral contusion, intracranial hematomas, and diffuse axonal injury were revealed. All patients were comatose (Glasgow Coma Score 3-8) at admission. Outcome scales were not taken into account. The study was conducted between December 2003 and November 2004.
Biostatistical Analysis
We calculated both the linear correlation coefficient and the Spearman rank-order correlation coefficient. 26 We assumed that the dependence is significant if p value Ͻ0.05 for both methods simultaneously. All statistical analyses and plots were done using Matlab 6.0, release 12 (The MathWorks). We measured the correlation of ICP to IOP, MAP to IOP, and MAP to ICP. 
RESULTS
Out of the 22 patients, 5 patients had a positive linear correlation and 2 patients had a negative correlation of ICP to IOP. The range for the positive correlation coefficient was 0.5457 to 0.8762, whereas for the negative it was -0.8252 to -0.6566. However, calculating both linear and Spearman rank-order correlation coefficients, we found that the correlation between ICP and IOP was significant in only two patients (patients 14 and 22) . Dependence analysis for a sample patient (patient 7) is presented in Figure 1 . Dependence between ICP and IOP for all patients is presented in Figure 2 . Note that patients with significant correlation between ICP and IOP (patients 14 and 22) could be treated as special cases. The IOP values of patient 14 are extremely high compared with the corresponding values in the whole population. In spite of this, there were no special features in patients who had a positive correlation between ICP and IOP that could have lead to any conclusions.
We found a significant correlation between MAP and IOP in 12 patients (i.e., for ϳ55% of the tested population). All of these patients have a positive correlation, which ranges from 0.5202 to 0.9650 for the linear correlation coefficient and is between 0.6520 and 0.9908 for the Spearman rankorder correlation coefficient. However, we found that the correlation between MAP and ICP is significant in only three patients (patients 8, 9, and 10). The correlation between MAP and IOP is significant, but neither ICP and IOP nor MAP and ICP are correlated. Globally, linear dependence can be observed only between MAP and IOP.
DISCUSSION
The study suggests no correlation between IOP and ICP and significant correlation between MAP and IOP. It contributes to the controversy that surrounds the recent literature. Recent articles by Sheeran et al. 8 and Lashutka et al. 11 support the use of intraocular pressure as an acute measure of intracranial pressure. Our study utilizes a slightly different approach that might be the cause of negative result. Each patient was observed for a longer period of time (2 to 6 days). Minimal number of measurements per day was three. Hemodynamic instability was not a cause of exclusion. There were no dramatic changes in central venous pressure but frequent changes in arterial pressure. The MAP fluctuations were associated with significant IOP fluctuations in 12 patients (positive correlation) without marked changes in ICP. It could suggest that MAP-related regulation of IOP is probably present in patients with intracranial abnormalities.
Results from animal studies suggest that large ICP changes are necessary to cause IOP rise. 15 We observed large rises in ICP above the level of 50 mm Hg in three patients (15, 17, and 21) . In patient 15, the IOP did not change; in patient 17, the IOP rose significantly but the MAP was very high; in patient 21, the ICP value reached 110 mm Hg and the IOP dropped to 4.2 mm Hg and it was associated with brain death. It could suggest that the intraocular pressure is not associated directly with the intracranial pressure but rather with cerebral hemodynamics (cerebral blood flow).
Physiologic and anatomic relationships between ICP and IOP are still unknown and potential ways of influence are hypothetical. The cerebrospinal fluid is separated from the eyeball and the optic nerve by a fibrous tissue that limits pressure transmissions. The hypothesis that elevations of ICP could be transmitted via the cavernous sinus and the superior ophthalmic vein was not clinically verified. It could be explained by the fact that the superior ophthalmic vein is connected not only with the cavernous sinus but also with the facial vein (via the angular vein). Pressure elevations in the cavernous sinus theoretically might divert blood flow toward the facial vein via the superior ophthalmic vein preventing IOP rise (there are no valves in the superior ophthalmic vein). Linear correlation between the central retinal vein pressure and ICP could also be anatomically explained. The central retinal vein directly enters the cavernous sinus and has not alternative anastomosis. The central retinal vein pressure elevation and macular edema reflect intracranial hypertension.
As far as sedation is concerned, Carter et al. 27 claim that intravenous administration of midazolam in a dose of 1 mg does not lower IOP, whereas Hirlinger et al. 28 observed a reduction in intraocular pressure after administration of midazolam in a much higher dose of 0.15 mg/kg intravenously with fentanyl after induction of anesthesia. Cesati et al. 29 investigated IOP after intravenous midazolam premedication (0.05 mg/kg body weight) and anesthesia induction. No reduction in IOP was observed. Such a dose of midazolam (0.05 mg/kg body weight) was chosen to prevent influence on the IOP examination.
We can expect that tonometry will not be an appropriate method for the assessment of ICP increases, particularly in patients suffering from TBI who are hemodynamically unstable when admitted to the ED setting.
